Biocryst Pharmaceuticals (NASDAQ:BCRX) Q3 2026 Earnings Call
Biocryst Pharmaceuticals (NASDAQ:BCRX) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Biocryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
- Period
- Q3 2026 earnings call
- Date
- Wed, Nov 4, 2026, 8:30 AM ET
On 6ix: 6ix.com/event/biocryst-pharmaceuticals-inc-bcrx-q3-2026-earnings-call
Latest news releases
- NASDAQ:BCRX — BioCryst to Report Third Quarter 2026 Financial Results on November 4 · Wed, Oct 21, 2026
- NASDAQ:BCRX — BioCryst Announces U.S. FDA Approval of ORLADEYO® 150 mg Oral Pellets for Adults and Adolescents with HAE · Wed, Oct 21, 2026